Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約 35 days | ¥ 25,500 |
5 mg | 約 35 days | ¥ 90,500 |
10 mg | 約 35 days | ¥ 135,000 |
説明 | Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3. |
ターゲット&IC50 | JAK2:5.0 nM, JAK1:3.9 nM, TYK2:4.8 nM, JAK3:0.7 nM |
別名 | ASP015K, JNJ-54781532 |
分子量 | 326.39 |
分子式 | C18H22N4O2 |
CAS No. | 944118-01-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: <1 mg/mL
Ethanol: <1 mg/mL
DMSO: 60 mg/mL (183.8 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Peficitinib 944118-01-8 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors Tyrosine Kinases JAK ASP015K Janus kinase lymphocytes JNJ 54781532 Inhibitor rheumatoid arthritis JNJ-54781532 inhibit JNJ54781532 IL-2 splenocytes inhibitor